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Abstract
Background: RT amplification reaction has revealed that various single viruses or viral co-infections caused acute
bronchiolitis in infants, and RV appeared to have a growing involvement in early respiratory diseases. Because remaining
controversial, the objective was to determine prospectively the respective role of RSV, RV, hMPV and co-infections on the
severity of acute bronchiolitis in very young infants.
Methods and Principal Findings: 209 infants (median age: 2.4 months) were enrolled in a prospective study of infants
,1 year old, hospitalized for a first episode of bronchiolitis during the winter epidemic season and with no high risk for
severe disease. The severity was assessed by recording SaO2% at admission, a daily clinical score (scale 0–18), the duration of
oxygen supplementation and the length of hospitalization. Viruses were identified in 94.7% by RT amplification reaction:
RSV only (45.8%), RV only (7.2%), hMPV only (3.8%), dual RSV/RV (14.3%), and other virus only (2%) or coinfections (9%). RV
compared respectively with RSV and dual RSV/RV infection caused a significant less severe disease with a lower clinical score
(5[3.2–6] vs. 6[4–8], p=0.01 and 5.5[5–7], p=0.04), a shorter time in oxygen supplementation (0[0–1] days vs. 2[0–3] days,
p=0.02 and 2[0–3] days, p=0.03) and a shorter hospital stay (3[3–4.7] days vs.6 [5–8] days, p=0.001 and 5[4–6] days,
p=0.04). Conversely, RSV infants had also longer duration of hospitalization in comparison with RSV/RV (p=0.01) and hMPV
(p=0.04). The multivariate analyses showed that the type of virus carried was independently associated with the duration of
hospitalization.
Conclusion: This study underlined the role of RV in early respiratory diseases, as frequently carried by young infants with a
first acute bronchiolitis. RSV caused the more severe disease and conversely RV the lesser severity. No additional effect of
dual RSV/RV infection was observed on the severity.
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Introduction
Acute bronchiolitis is the most common respiratory disease in
infants under 2 years of age. Although most infants recover within
five days, annual bronchiolitis hospitalization among infants
younger than 1 year has been assessed at 31.2/1000 [1]. During
the epidemic season, up to 90% of this acute wheezing disease has
been attributed to respiratory syncytial virus (RSV). However, the
recent use of RT amplification reaction has modified our
knowledge as regards the epidemiology during the winter epidemic
season, revealing the role of other viruses such as rhinovirus (RV)
and human metapneumovirus (hMPV), and at a less frequency
enterovirus, coronavirus or bocavirus [2]. Moreover, dual viral
infection appeared more frequently, estimated from 20% to 30%
[3–5]. Accompanying the change in epidemiology, the question
was raised concerning severity as regards these various carried
viruses. The results have remained controversial. For some
authors, the severity was similar between RSV and RV [6],
RSV and hMPV bronchiolitis [4]. However, Korppi et al. [6]
defended the fact that RSV might be responsible for a more severe
disease, as this virus concerned younger infants [7]. In comparison
with RSV, RV has also been associated with either a more severe
bronchiolitis [3], or a shorter duration of the disease [8]. In one
study, hMPV caused more moderate bronchiolitis than those
related to RSV [9]. The involvement of viral co-infections in the
expression of the severity of bronchiolitis was also debated. In fact,
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severity and increase the duration of hospitalization [10–12].
Conversely, Xepapadaki et al [4] and Papadopoulos et al. [3] did not
confirm the aggravation effect of these dual infections. Recently, the
fact that carrying at least any two viruses augmented the risk to be
transferred to PICU has been reported [5]. The aim of this
prospective study was to assess the clinical severity and viral etiology
in infants hospitalized with a first episode of acute bronchiolitis
during the epidemic season. Within this very young population,
RSV caused more marked severe bronchiolitis than did RV, and
RV co-infection but neither aggravated the clinical features nor the
length of the hospitalization. HMPV related bronchiolitis were
more frequently associated with hypoxemia at admission.
Study design, patients and methods
Ethics statement. This study was conducted according to
the principles expressed in the Declaration of Helsinki. The
French North West I Hospital Ethics Committee (Comite ´d e
Protection des Personnes ‘‘Nord-Ouest I’’, University Hospital, Rouen,
France) approved the research study. All patients provided written
informed consent for the collection of samples and subsequent
analysis.
A prospective multicentre study was conducted in infants
hospitalized for a first episode of acute bronchiolitis during three
epidemic seasons (November to March 2002–2004). Four
pediatric centers in a same geographical location (North West of
France) participated in the study. Inclusion criteria were as follows:
Infants aged from 1 month to 1 year, requiring hospitalization for
a first episode of acute bronchiolitis. The diagnosis was based on
dyspnea and wheezing or crackles associated with lung hyperin-
flation on chest X-ray. Exclusion criteria were any administration
of steroids, history of wheezing, or underlying disease susceptible
to modify the natural outcome (immunodeficiency, chronic lung
disease, cystic fibrosis, congenital heart disease etc.). Medical
history and demographic data were collected. Atopy was defined
by asthma, allergic rhinitis or eczema in first degree relatives, or by
eczema in infants. Diagnosis and severity of bronchiolitis were first
established in the Pediatric Emergency Department, where the
decision to be hospitalized was made. The severity of the disease
was assessed with SaO2%, a clinical score, the duration of oxygen
requirement, and the length of hospitalization. The clinical score
associated standard criteria previously described [13,14] (Table 1).
Each item was scaled from 0 to 1 and the score varied from 0 to
18. Because the disease could worsen after admission, the infant
was further scored daily. The highest score observed during the
hospitalization was retained for determining the severity of the
disease. The discharge of the patient was based on the following
criteria: SaO2%$95%, normal respiratory rate (RR#47/min for
infants aged ,2 mo, and #42/min when older) and no alteration
in feeding during the past 24 h nor other complications directly
related to the bronchiolitis. The length of the hospitalization was
calculated as the time between the admission and the validation of
the discharge criteria. Any prolonged hospitalization for other
reasons was therefore not taken into account. The Rouen Hospital
Ethics Committee approved the research study and informed
consent was obtained from the parents.
Detection of viruses
Antigens for RSV, influenza virus A and B, parainfluenza type
1, 2, and 3, and adenovirus were detected by direct immunoflu-
orescence assay (DFA) from nasopharyngeal aspiration (NPA)
samples, employing commercial monoclonal antibodies conjugat-
ed with fluorescein isothiocyanate (IMAGEN, Dako, Denmark)
[15]. A positive result was indicated by DFA, and to the finding of
at least one cell showing a typical fluorescence pattern, provided
that at least 20 respiratory cells were available in the sample. All
the samples were further analyzed by using molecular methods
including four multiplex RT-PCR, as previously described [2],
and an adenovirus PCR (Adenovirus ConsensusH, Argene). The
multiplex PCR targeted 14 respiratory viruses: RSV, influenza
viruses A, B and C, hMPV, parainfluenza viruses (PIV) types 1, 2,
3, 4, RV, enterovirus (EV), human coronavirus OC43, 229E and
NL63. The molecular methods allowed us to confirm the presence
of the viruses which were detected by the DFA, and to find viruses
that were not included in the DFA.
Statistical analysis
Pairwise correlation among the SaO2%, clinical score, length of
oxygen supply, demographic data and hospitalization were
assessed using Spearman’s rank test (Rho). For nominal variables,
Table 1. clinical score.
0 1=mild 2=marked
Intercostals retraction
Xiphoid retraction
Chest movement synchronization
Nasal flaring
Score I=
01 2
Wheezing None E E+I or no more sounds
I/E ratio I.EI = E I ,E
Reactivity Good Tired Poor
Feeding Unchanged enteral parenteral
Lung hyperinflation Chest X-ray No Yes with CTR$0.5 Yes with CTR,0.5
Score II=
final score=Scores I+II
E=expiratory; I=inspiratory; CTR=cardiothoracic ratio.
*Chest X-ray was assessed once at the admission.
doi:10.1371/journal.pone.0004596.t001
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were also used. Univariate analyses were performed to assess the
associationbetweenthesevariablesand severitycriteria.Severitywas
then analyzed as nominal variables using for clinical score, length of
oxygen supplementation and hospitalization the 50
th percentile, and
for SaO2% the significant hypoxemia threshold of 92%. Multivar-
iate analyses were performed by using stepwise logistic regression to
select variables independently associated with the virus-related
severity. A Chi-2 test, and Fischer’s test if required, was applied for
the qualitative analyses. In all the analyses, a value of p,0.05 was
considered statistically significant. The data were displayed as
median and 25
th–75
th quartiles. The statistical analyses were
performed using Statview 5.0 (SAS Institute Inc., Cary-NC CA).
Results
Two hundred nine infants were included. The median age was
2.4[1.6–3.9] months, range (1–10.5), of which 91%,6 months,
and the sex ratio was 1.3. A total of 94.7% infants carried at least
one virus (Table 2), 93.2% of RSV-associated bronchiolitis were
detected by IF and the remaining 6.7% by RT-PCR. Twenty-one
(10%) infants had a severe bronchiolitis with a clinical score .7,
96 (46.9%) required oxygen supplementation, seven were
transferred to PICU and four intubated.
Severity and infant characteristics
The clinical score, length of oxygen supplementation and
duration of hospitalization were significantly correlated to each
other: score and duration of oxygen supplementation (Rho=0.482,
p,0.0001); score and length of hospitalization (Rho=0.393,
p,0.0001);durationofoxygen supplementation and hospitalization
(Rho=0.527, p,0.0001). The age was inversely correlated with the
length of hospitalization (Rho=20.296, p,0.0001). The girls had
an higher clinical score than the boys: 6 [4–8] vs. 5 [4–7] p,0.036;
the infants with a history of familyatopyhad a lowerclinical score (5
[4–7] vs. 7[5–9], p=0.002) and required a shorter time of oxygen
supplementation (2[0–4]d vs. 1[0–3]d, p=0.009). Passive tobacco
exposure was associated with a longer duration of hospitalization:
5[4–8] vs. 5 [3–6], p=0.004.
Severity by type of virus
The dichotomous analysis by identified virus is displayed in
Table 3. The univariate logistic regression showed that to carry
RSV increased the risk to have a clinical score .6 (OR=2.4[1.1–
4.3]95%CI), oxygen supplementation (OR=2.5[1.28–4.97]
95%CI) and hospitalization.5 d (OR=6.2[2.99–12.80]95%CI).
To carry RV decreased the risk to be hospitalized.5d
(OR=0.43[0.23–0.83]95%CI) and hypoxemic at the admission
(OR=0.17[0.13–0.99]95%CI). The presence of hMPV lowered
the risk to be hospitalized.5 d (OR=0.33[0.11–0.96] 95%CI)
and increased the risk to have SaO2%#92% at the admission
(OR=5.88[1.98–16.9]95%CI).
Severity and single or dual viral infection
The large variety of viruses and viral co-infections found
restricted the analyses to RSV alone, RV alone, dual RSV/RV
infection, and hMPV alone, the other groups being too small
(Table 2). For this subpopulation, the clinical score was 6[4–7],
SaO2% was 95[92.5–97]% length of O2 supplementation and
hospitalization were 1[0–3] day and 5[4–7] days, respectively.
There was a significant difference in the severity between RV,
RSV, RV/RSV and hMPV as shown in Table 4 and Figure 1.
Compared to RSV, infants with RV had a lower risk to present a
severe disease as regards being supplied with oxygen (OR=
0.29[0.09–0.90]95%CI) and to stay .5 days (OR=0.11[0.03–
0.37]95%CI). This was also observed for hMPV with a lower risk
to be hospitalized.5 days (OR=0.09[0.019–0.53]95%CI). Con-
versely, the risk to have SaO2%#92% at admission tended to
increase in hMPV compared with RSV and RSV/RV bronchi-
olitis: OR=4[1.0–16.7]95%CI and OR=14.2[1.92–100]95%CI,
respectively. All the infants suffering from RV bronchiolitis had
SaO2%.92%, preventing the calculation of odds ratio. The
multivariate analyses including the need for oxygen, clinical score,
SaO2% and age showed that only the risk to stay ,5 days
decreased in RSV/RV (OR=0.26[0.09–0.76]95%CI), RV (OR=
0.13[0.03–0.57]95%CI) and hMPV (OR=0.09[0.01–0.69]
95%CI) compared with RSV bronchiolitis.
Discussion
The availability of multiplex RT amplification reactions has
modified our knowledge as regards the viral epidemiology of the
Table 2. characteristics of the population studied.
N=209 n %
Boys 118 57.5
Familial history of atopy 142 67.9
Personal history of atopy 48 23.0
Premature term .34 weeks
* 12 5.7
Passive tobacco 128 61.2
Causes of hospitalization
Severity 135 64.6
Age ,3 months 126 60.3
Geographical care access 22 10.5
Socioeconomic difficulties 13 6.2
Identified viruses 94.7
RSV 134 64.1
RV 56 26.8
HMPV 16 7.6
Other
** 16 7.6
Viral etiology
RSV alone 96 45.8
RV alone 15 7.2
HMPV alone 8 3.8
Other virus alone
*** 42 . 0
Dual RSV/RV infection 30 14.3
Dual RSV/hMPV infection 3 1.4
Dual hMPV/RV infection 5 2.4
Other co-infections
**** 11 5.2
Severity median [25
th–75
th]
Clinical Score 5[4–7]
%SaO2 95[92–97]
Oxygen supplementation (days) 1[0–3]
Length of hospitalization (days) 5[3.8–7]
*Gestational age ,34 weeks was an exclusion criteria.
**Enterovirus [EV] (n=9), coronavirus (n=2), influenza A virus [MIA] (n=1),
parainfluenza virus [PIV 1+] (n=2) or PIV 3 (n=2).
***MIA (n=1), PIV 1 (n=2) or PIV 3 (n=1).
****RSV/coronavirus (n=2), RSV/EV (n=2), RSV/RV/EV (n=5), RSV/RV/MIA(n=1).
doi:10.1371/journal.pone.0004596.t002
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considered the unique etiologic agent. It is now well established
that rhinoviruses and human metapneumoviruses have also been
involved in infantile bronchiolitis. However, the phenotypes as
regards these new viruses should to be clarified, as the available
data still remain controversial. In the present study, by analyzing
various severity criteria, we showed that RSV remained the most
aggressive agent in young infants, and conversely RV caused less
severe bronchiolitis. Furthermore, dual RSV/RV infection did not
aggravate the severity of illness, tending to be more moderate than
RSV related bronchiolitis. In addition, hMPV bronchiolitis has
been distinguished by a more marked hypoxemia at the admission.
The use of molecular amplification reaction was expected to
achieve a better viral detection, which ranged from 70.5% to
96.1% in comparable studies [2,3,5,16,17]. In agreement with our
previous reported experience [2], the high rate of virus detected
(94.7%) in this study underlined the various viral etiologies during
the RSV epidemic season in very young infants with acute
bronchiolitis. Dual RSV/RV infection was shown as the second
cause of bronchiolitis, while RSV remained the first and, RV and
Table 3. Severity and, RSV and RV or hMPV virus carriage.
Severity RSV RSV p* RV RV p* HMPV HMPV p*
+ve 2ve +ve 2ve +ve 2ve
n=134 n=47 n=56 n=125 n=16 n=165
Age (months) 2.4[1.5–3.6] 2.3[1.6–5.0] - 2.4[1.6–4.3] 2.41.6–3.6] - 2.6[1.7–5.5] 2.4[1.5–3.6] -
Clinical score 6[4–7] 5[3–6] 0.004 5[4–6.5] 5.5[4–7] - 5[3.5–7] 5[4–7] -
#6 (%) 18.1 66 0.04 57.1 50 0.01 62.5 51.2 0.056
.6 (%) 81.9 34 42.9 50 37.5 48.7
O2 (days) 2[0–3] 0[0–2] 0.004 1[0–3] 1[0–3] - 0.5[0–4] 1[0–3] -
No (%) 34.7 57.5 0.009 53.6 60.8 - 50 59.3 -
Yes (%) 65.3 42.5 46.4 39.2 50 40.6
%SaO2 95[92–97] 95[92–96.2] - 95[93–96] 95[92–97] - 91.5[90–95.5] 95[93–97] 0.008
#92% (%) 18.1 17.8 - 9 21.7 0.056 50 14.7 0.002
.92% (%) 81.9 82.2 91 78.2 50 85.3
Hospitalization (days) 6[4–8] 4[3–5] ,0.0001 4[3–6] 6[4–8] 0.005 4[3–7.5] 5[4–7] -
#5 (%) 39.2 70.2 ,0.001 51.8 32 0.01 46.4 35.7 -
.5 (%) 67 29.7 48.9 68 53.6 64.2
N Kruskall-Wallis non parametric test. Results are expressed in median[25
th–75
th]quartiles or in percentage, as indicated in the table.
doi:10.1371/journal.pone.0004596.t003
Table 4. Severity and single or dual viral infections.
Severity (unit) RSV RVS/RV RV hMPV p*
n=96 n=30 n=15 n=8
Age (months) 2.2 1.5–3.4] 2.7 1.8–3.6] 1.7[1.4–4.8] 2.6[2.2–5.4] -
Birth weight (g) 3290 [2952–3592] 3375 [3000–3700] 3280 [2832–3585] 3230 [3000–3605] -
Boys (%) 60.4 50.7 40 50 -
Family atopy (%) 65.6 63.3 80 62.5 -
Personal atopy (%) 22.9 30 13.3 62.5{{ 0.08
Passive tobacco exposure (%) 63.5 46.7 53.3 62.5 -
Onset of symptoms (days)
Rhinitis 2[2–4] 3[1.2–5.7] 1.5[1–3]
1 6.5[2–11]
{ 0.04
Cough 2[1–4] 3[2–5] 3[2–4.7]
# 5[2–10]
* 0.08
Dyspnea 1[0.5–2] 1[0.7–2.2] 1.5[1–3] 2[1–2] -
Wheezing 1[0–2] 1[0–2] 2[1–4.5]
1 1[0.5–2] 0.13
Clinical score 6 [4–8] 5.5 [5–7] 5[3.2–6]
1# 5.5[3.5–8] 0.12
Duration of O2 supplementation (days) 2[0–3] 2[0–3] 0[0–1]
1# 0.5[0–2.5] 0.13
%SaO2 95[92–97] 94[93–96] 96[95–97] 92.5[89–95.5]
*{ 0.14
Length of hospitalization (days) 6 [5–8] 5 [4–6]
¥ 3 [3–4.7]
1# 3.5[2.5–4.5]
{ 0.0002
Results are expressed in median [25
th–75
th] quartiles.
*Kruskall-Wallis non parametric test. p,0.05:
{hMPV vs. RSV;
{hMPV vs. RV;
1RV vs. RSV;
¥RVS/RV vs. RSV;
#RV vs.
RSV/RV; p,0.1.
*hMPV vs. RSV.
doi:10.1371/journal.pone.0004596.t004
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RV and hMPV was indeed comparable to other studies
[3,5,8,16,17], but we conversely found no difference in the age
of the infants as regards the viruses involved. On the other hand,
the seldom detection of parainfluenza virus or influenza A virus
could be explained respectively by the recruitment restricted to the
winter season and the very young age of the infants. The other
viruses that were encountered were frequently found among
various combinations of co-infection. Lastly, bocaviruses, preva-
lent viruses in acute bronchiolitis, were not researched in this
series. However, its pathogenicity was to date uncertain, as it is
mainly detected in coinfection [18].
We chose to enroll only hospitalized infants with a first acute
bronchiolitis, with no underlying disease and no previous
treatment in the way to respect the natural history. In this selected
very young population, the distribution of the viruses allowed
comparing infants with four different viral carriages: RSV alone,
RV alone, hMPV alone and dual RSV/RV infection. Interest-
ingly, the infants with RV had a less severe disease than those who
carried either RSV alone or dual RSV/RV infection. Further-
more, they recovered quickly with a shorter stay in hospital. This
result was contrary to the previously reported series from
Papadopoulos et al [3]. These authors established that RV caused
a 5.6 fold risk to be included in a high risk group defined by a
clinical score above the 50
th percentile, and an earlier admission in
the emergency unit. In our study, 56% of RSV infants and only
33% of RV had a score above this threshold and the infants with
RV bronchiolitis presented at a later stage of the disease than the
RSV infants. In addition, these authors found a difference in age
and weight as regards the virus carried. Therefore, the
discrepancies between both studies may likely be explained by
the different population enrolled, and the clinical assessment of
severity. More recently, Richard et al. [5] reported no difference in
the distribution of RV or RSV among young infants hospitalized
either in short term unit or PICU. Mansbach et al. [19] observed a
better outcome for infants with RV bronchiolitis in Emergency
Departments, and RSV was in other series identified as the more
causative aggressive agent [12,20]. Lastly, hMPV bronchiolitis
featured a more initial hypoxemic disease without worsening the
further outcome, as they differed in a shorter hospital stay from
RSV but not from RV or RSV/RV illness. This associated
hypoxemia was also observed by Mullins et al. [21] but not
reported in other studies [4,22].
The statement of viral co-infections in acute bronchiolitis raised
the question of a cumulative pathogenic effect and consequently a
more severe disease, although other hypotheses as successive
infections or healthy carriage might be also supported [23]. In this
study, the clinical severity of dual RSV/RV infection was
comparable to that observed with RSV, but differed in a shorter
duration of hospitalization in the coinfected infants. This
underlined that RSV remains the most aggressive virus on the
bronchi, and masked a clinical relevant additional effect of RV, in
agreement with previous reports [3,12,20]. The other co-infections
were not analyzed, because of the small number of infants in each
category. Among the coinfections, the comparison of RSV and
dual hMPV/RSV lower respiratory tract infection has been the
most studied, and was associated with either no greater severity
[16,24] or an increased risk to undergo mechanical ventilation
Figure 1. Severity of acute bronchiolitis with regards to the viral etiology. The following groups were compared: RVS alone (n=96), RV
alone (n=15), dual RVS/RV infection (n=30), and hMPV alone (n=8). The studied criteria of severity were clinical score (A), SaO2% at the admission
(B), oxygen supplementation (C) and duration of hospitalization (D).
doi:10.1371/journal.pone.0004596.g001
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conferred a 2.7- fold increase in the risk to be admitted in PICU
for ventilator assistance. This studied population was however
characterized by a high proportion of premature newborns or
history of underlying chronic illness and the assessment of the
severity differed completely.
The young age has been established as one of the most relevant
risk factors in RSV bronchiolitis. Commonly detected in infants
younger than those who carried RV [3,6] or hMPV [22,26], RSV-
associated severity was suggested therefore to be related to a
younger age [6]. Although the age was strongly correlated with the
duration of hospitalization, this hypothesis was not supported in
our study, as the infants forming each viral subgroup were aged in
a similar range. In addition, we found a slight increase of clinical
severity in the girls, a longer time of hospitalization due to tobacco
exposure and a protective effect of family history of atopy, which
was also observed by Bradley et al. [27]. The multivariate analysis
confirmed that the type of virus involved in the infection
influenced independently the length of hospitalization. Other
known virus-related risk factors of severity were not studied in this
series, as well as the viral load [28], the host dependent [29] or
virus-related inflammatory response [14].
In conclusion, the severity of a first acute episode of
bronchiolitis in very young infants depends on the causative
agents. Although RSV remains the main concern in this frequent
respiratory illness, the prevalence of dual RSV/RV and RV
infection is high and permitted to reconsider the use of
corticosteroids [30]. However, proposing new management
implies the routine use of RT molecular amplification, which is
currently the only tool to easily target the detection of rhinoviruses,
but would include an increasing cost in the investigations.
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